Column

Clinical Pathways GPS

Atypical Players in the Treatment Landscape

11/27/2017

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

CVS pharmacy recently made an offer to acquire Aetna Health Plan for $66 billion.1 This is a true game changer for two reasons: first, it represents the most significant national integration of service provider and...

CVS...

11/27/2017

Journal of Clinical Pathways

Editor's Page

Mergers and Acquisitions in Clinical Pathways

11/27/2017

Winston Wong , PharmD;

This time of year brings about holidays, time with family, and time for reflection as we move into a new calendar cycle. For those of us who work in medicine—no matter the specialty or area—it can also be a time for...

This...

11/27/2017

Journal of Clinical Pathways

Editor's Page

Integrating Gene Therapy Into Value-Based Care

10/16/2017

Winston Wong , PharmD;

Medical advances emerge swiftly, and sometimes surprisingly. The rapid number of new products approved by the Food and Drug Administration (FDA) for the treatment and care of patients with cancer perfectly...

...

10/16/2017

Journal of Clinical Pathways

Clinical Pathways GPS

Looking for Leadership in Developing Pathways

10/16/2017

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Scott Guerin , PhD;

A clinical pathway can be defined as an “optimal sequencing and timing of interventions by physicians, nurses, and other staff for a particular diagnosis or procedure.” As organizations new to pathways look to...

A...

10/16/2017

Journal of Clinical Pathways

Pharma Insights

Orphan Drugs: Understanding the Payer Perspective

10/16/2017

Hetty A. Lima , BSPharm, RPh, FASHP;

Kellie Rademacher , PharmD;

New drugs for orphan and rare diseases have the potential to positively impact the lives of patients where historically few or no treatments had been available to manage the disease. The passage of the Orphan Drug...

New...

10/16/2017

Journal of Clinical Pathways

Clinical Pathways GPS

Clinical Pathways Guiding Where and When

09/19/2017

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Clinical pathways most often guide treatment decisions based on a diagnosis, but what about assistance for directing where and when care is most effectively rendered? Improving clinical and financial outcomes...

...

09/19/2017

Journal of Clinical Pathways

Pharma Insights

Are Formulary Exclusion Lists Aligned or Contrary to the Shift to Value-Base Care?

09/19/2017

Larry Blandford , PharmD;

Andrew Cournoyer , RPh, MBA;

The use of formulary exclusion lists continues to expand, with clear impacts to the perception and use of all related medications. Annual updates to these lists suggest a need for careful evaluation by benefit...

The...

09/19/2017

Journal of Clinical Pathways

Editor's Page

Moving the Clinical Pathways Conversation Forward

09/18/2017

Winston Wong , PharmD;

September brings about many things: the end of summer, the beginning of a new school term, and a march toward the conclusion of another calendar year. For those of us at Journal of Clinical Pathways, September marks...

...

09/18/2017

Journal of Clinical Pathways

Clinical Pathways GPS

Truly Patient-Centered Clinical Pathways

08/16/2017

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Scott Guerin , PhD;

For clinical pathways to be most effective, they need to accommodate many external factors impacting patients. These include issues such as the social determinants of health, as well as access to care that can impact...

For...

08/16/2017

Journal of Clinical Pathways

Editor's Page

A Moment in the Spotlight for Clinical Pathways

08/16/2017

Winston Wong , PharmD;

Summer is a time of rest and relaxation, when we recharge our batteries in order to gain the energy needed to propel us through the rest of the year. That’s especially true here at Journal of Clinical Pathways (JCP),...

Summer...

08/16/2017

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Column

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products